ATE476429T1 - Verfahren zur synthese von n-ä3-ä(2- methoxyphenyl)sulfanyl-2-methylpropyl-3,4-dihyd o-2h-1,5-benzoxathiepin-3-amin - Google Patents

Verfahren zur synthese von n-ä3-ä(2- methoxyphenyl)sulfanyl-2-methylpropyl-3,4-dihyd o-2h-1,5-benzoxathiepin-3-amin

Info

Publication number
ATE476429T1
ATE476429T1 AT07870250T AT07870250T ATE476429T1 AT E476429 T1 ATE476429 T1 AT E476429T1 AT 07870250 T AT07870250 T AT 07870250T AT 07870250 T AT07870250 T AT 07870250T AT E476429 T1 ATE476429 T1 AT E476429T1
Authority
AT
Austria
Prior art keywords
dihyde
benzoxathiepine
sulfanyl
methylpropyl
methoxyphenyl
Prior art date
Application number
AT07870250T
Other languages
English (en)
Inventor
Bernard Vacher
Yves Brunel
Jean-Louis Maurel
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE476429T1 publication Critical patent/ATE476429T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT07870250T 2006-11-08 2007-11-06 Verfahren zur synthese von n-ä3-ä(2- methoxyphenyl)sulfanyl-2-methylpropyl-3,4-dihyd o-2h-1,5-benzoxathiepin-3-amin ATE476429T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609815A FR2908132B1 (fr) 2006-11-08 2006-11-08 Procede de synthese du n-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine
PCT/FR2007/001831 WO2008068403A2 (fr) 2006-11-08 2007-11-06 Procede de synthese du n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine

Publications (1)

Publication Number Publication Date
ATE476429T1 true ATE476429T1 (de) 2010-08-15

Family

ID=38066470

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07870250T ATE476429T1 (de) 2006-11-08 2007-11-06 Verfahren zur synthese von n-ä3-ä(2- methoxyphenyl)sulfanyl-2-methylpropyl-3,4-dihyd o-2h-1,5-benzoxathiepin-3-amin

Country Status (27)

Country Link
US (1) US7982054B2 (de)
EP (1) EP2089374B1 (de)
JP (1) JP5180965B2 (de)
KR (1) KR101390486B1 (de)
CN (1) CN101535287B (de)
AR (1) AR063592A1 (de)
AT (1) ATE476429T1 (de)
AU (1) AU2007330711B2 (de)
BR (1) BRPI0718702A2 (de)
CA (1) CA2668951C (de)
DE (1) DE602007008284D1 (de)
ES (1) ES2350324T3 (de)
FR (1) FR2908132B1 (de)
HK (1) HK1131970A1 (de)
IL (1) IL198528A (de)
MA (1) MA30800B1 (de)
MX (1) MX2009003957A (de)
NO (1) NO20091980L (de)
NZ (1) NZ576442A (de)
PL (1) PL2089374T3 (de)
PT (1) PT2089374E (de)
RU (1) RU2414464C9 (de)
TN (1) TN2009000176A1 (de)
TW (1) TWI397527B (de)
UA (1) UA94632C2 (de)
WO (1) WO2008068403A2 (de)
ZA (1) ZA200902732B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2979823B1 (fr) * 2011-09-13 2013-09-27 Pf Medicament Utilisation du 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour le traitement du cancer et en particulier pour la prevention et/ou le traitement des metastases cancereuses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868779B1 (fr) * 2004-04-09 2008-08-22 Pierre Fabre Medicament Sa Procede de synthese et intermediaires de benzoxathiepines

Also Published As

Publication number Publication date
CN101535287A (zh) 2009-09-16
AU2007330711B2 (en) 2011-11-03
EP2089374B1 (de) 2010-08-04
WO2008068403A3 (fr) 2008-11-27
JP5180965B2 (ja) 2013-04-10
ES2350324T3 (es) 2011-01-21
MA30800B1 (fr) 2009-10-01
US7982054B2 (en) 2011-07-19
AU2007330711A1 (en) 2008-06-12
TW200835688A (en) 2008-09-01
WO2008068403A2 (fr) 2008-06-12
RU2009121560A (ru) 2010-12-20
FR2908132B1 (fr) 2008-12-19
NZ576442A (en) 2012-03-30
ZA200902732B (en) 2010-02-24
DE602007008284D1 (de) 2010-09-16
PT2089374E (pt) 2010-11-04
CA2668951C (fr) 2012-06-26
IL198528A (en) 2012-12-31
HK1131970A1 (en) 2010-02-12
MX2009003957A (es) 2009-04-28
AR063592A1 (es) 2009-02-04
PL2089374T3 (pl) 2011-01-31
KR101390486B1 (ko) 2014-05-19
CN101535287B (zh) 2013-02-27
IL198528A0 (en) 2010-02-17
FR2908132A1 (fr) 2008-05-09
NO20091980L (no) 2009-06-08
RU2414464C9 (ru) 2011-11-10
RU2414464C2 (ru) 2011-03-20
UA94632C2 (en) 2011-05-25
EP2089374A2 (de) 2009-08-19
BRPI0718702A2 (pt) 2014-01-07
TWI397527B (zh) 2013-06-01
TN2009000176A1 (fr) 2010-10-18
JP2010509296A (ja) 2010-03-25
CA2668951A1 (fr) 2008-06-12
US20090318709A1 (en) 2009-12-24
KR20090082463A (ko) 2009-07-30

Similar Documents

Publication Publication Date Title
ATE538111T1 (de) Verfahren zur synthese von 5- alkoxymethylfurfuralethern
ATE474845T1 (de) Verfahren zur synthese von saccharose-6-estern
DE502005010794D1 (de) Verfahren zur kontinuierlichen katalytischen Hydrierung
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE459416T1 (de) Verfahren zur beseitigung von endokrin wirksamen verbindungen
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE530558T1 (de) Verfahren und verbindungen zur herstellung von natriumglucose-co-transporter-2-hemmern
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DK2076330T3 (da) Fremgangsmåde til fremstilling af katalysatorer
DE602006012585D1 (de) Verfahren zur Förderung von Michael-additionsreaktionen
DE502005010287D1 (de) Verfahren zur hydrocyanierung
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
ATE490248T1 (de) Heteroarylharnstoffderivate zur hemmung von chk1
ATE518173T1 (de) Verfahren zur kollisionsvermeidung
DE602005024305D1 (de) Verfahren zu synthese von glycolonitril
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE514813T1 (de) Verfahren zur hersttellung von hochausbeutezellstoff
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
ATE540585T1 (de) Verfahren zur herstellung von tomatenpaste
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
ATE554088T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten
ATE542533T1 (de) Verfahren zur herstellung von isothiazol- derivaten
DE502005002018D1 (de) Verfahren zur Formung von Signalspektren
ATE518829T1 (de) Verfahren zur herstellung von escitalopram

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties